$112 Million Fake Research Scandal Rocks Top College
The whistleblower in the case will receive an estimated $33 million
Alex Reid here with your Monday roundup.
Here at Clear Health Now, we always say: be skeptical!
Modern scientific literature is incredibly valuable, and we've discovered life-changing information in medical journals and university reports.
But we've also discovered crap.
Or even worse, information that appears valuable but is later proven to be false, biased, or otherwise dangerously wrong.
So whether the source is a medical journal, a mainstream newspaper, or even Clear Health Now, you should always be skeptical, check the evidence, and form your own conclusions.
(That's why we pride ourselves in citing our sources and never being afraid to correct information we've published that turns out to be wrong.)
And that's true no matter how prestigious the source is...
Even if it's top research college Duke University.
Duke has just paid a $112 million settlement to the U.S. government after a whistleblower alleged:
"A researcher in [Duke's] pulmonary division had violated the False Claims Act, defrauding the government of millions of dollars...
[Performing] systematic and near-universal research fraud," including, in some cases, making up data outright "in lieu of actually performing experiments."
You can get the full story from NPR right here.
In other news, CEO Rob Solomon of crowdfunding site GoFundMe is alarmed by how much people use his service to raise money for medical bills.
According to Solomon, a full one-third of GoFundMe efforts are to help people with medical bills.
This alarming statistic speaks to problems across the board in medical health care, from patients suffering preventable ailments to a poorly functioning insurance system to massive cost overruns in the care itself.
You can get that full story from Kaiser Health right here.
And finally, to leave you on a positive note:
A federal health agency has publicly spoken out against marijuana's Schedule 1 classification as a highly restricted drug.
The agency, called the NCCIH, has also committed to funding more cannabis studies going forward, a remarkable shift in the government's stance from even a few years ago.
If you want to learn more about the incredible strides being made in cannabis research, go back to part 1 of our remarkable interview with Dr. Deb Kimless.
To your health,
President, Clear Health Now